The global Gene Expression Analysis Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product & Service (Reagents & Consumables, Instruments, Service), By Application (Drug Discovery & Development, Clinical Diagnostics, Others), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others).
The Gene Expression Analysis Market in 2024 continues to drive advancements in molecular biology and biomedical research, providing essential tools and technologies for studying gene expression patterns, regulatory mechanisms, and biological pathways underlying health, disease, and drug response. Gene expression Analysis involves the measurement and quantification of messenger RNA (mRNA) transcripts and non-coding RNAs to understand how genes are activated or suppressed in different cell types, tissues, and physiological conditions. The market experiences rapid growth driven by factors such as the increasing demand for personalized medicine, the rise of precision oncology and immunotherapy, and the growing adoption of gene editing and CRISPR technologies. Gene expression Analysis solution providers innovate to offer a range of platforms, including microarrays, quantitative polymerase chain reaction (qPCR), next-generation sequencing (NGS), and single-cell RNA sequencing (scRNA-seq), tailored to different research applications and throughput requirements. Additionally, advancements in assay sensitivity, multiplexing capabilities, and data Analysis software enable comprehensive profiling of gene expression signatures and biomarkers for disease diagnosis, prognosis, and therapeutic targeting. Furthermore, collaborations between research institutions, pharmaceutical companies, and biotechnology firms drive technology development, validation, and translation into clinical practice. As researchers seek to unravel the complexities of gene regulation and disease mechanisms, the gene expression Analysis market remains instrumental in accelerating scientific discoveries, drug development, and precision healthcare initiatives.
The global Gene Expression Analysis Market Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Gene Expression Analysis Market Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Gene Expression Analysis Market Industry include- 10x Genomics Inc, Agilent Technologies Inc, BGI Genomics Co. Ltd, Bio-Rad Laboratories Inc, BioSpyder Inc, CD Genomics, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, GenScript Biotech Corp, Illumina Inc, Integrated DNA Technologies Inc, LGC Ltd, NanoString Technologies Inc, Oxford Gene Technology IP Ltd, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, Promega Corp, QIAGEN N.V., Revvity Corp, Standard BioTools Inc, Takara Bio Inc, Thermo Fisher Scientific Inc, Twist Bioscience, Zymo Research Corp
A significant trend in the Gene Expression Analysis Market is the shift towards single-cell gene expression analysis techniques. Traditional bulk RNA sequencing methods provide average gene expression profiles from a population of cells, masking cellular heterogeneity and limiting insights into individual cell behaviors. Single-cell gene expression analysis allows researchers to dissect cellular diversity and identify rare cell populations, offering a more comprehensive understanding of complex biological systems. As advancements in technology enable high-throughput single-cell analysis with improved sensitivity and resolution, there's a growing adoption of single-cell sequencing platforms in research laboratories and pharmaceutical companies, driving market growth in the gene expression analysis segment.
A key driver propelling the Gene Expression Analysis Market is the increasing demand for personalized medicine and precision therapeutics. Gene expression profiling plays a critical role in understanding disease mechanisms, identifying biomarkers, and predicting treatment responses in personalized medicine approaches. With the growing emphasis on targeted therapies and precision diagnostics, there's a rising demand for gene expression analysis technologies that enable accurate profiling of molecular signatures and patient stratification for tailored treatment regimens. Pharmaceutical companies, healthcare providers, and research institutions are driving investments in gene expression analysis platforms and services to support drug discovery, clinical trials, and patient care in the era of precision medicine, fueling market growth and innovation in gene expression analysis.
An opportunity in the Gene Expression Analysis Market lies in the expansion into emerging applications such as single-cell diagnostics. While single-cell gene expression analysis is predominantly used in research settings, there's potential to translate these technologies into clinical diagnostics for disease diagnosis, prognosis, and monitoring. By developing robust and validated assays for single-cell diagnostics, companies can capitalize on the growing demand for molecular diagnostics in healthcare settings, offering improved patient stratification, treatment decision-making, and disease monitoring. Additionally, expanding into emerging fields such as single-cell epigenomics and spatial transcriptomics presents opportunities for companies to diversify their product portfolios and address unmet needs in personalized medicine and clinical diagnostics, driving market expansion and revenue growth in the gene expression analysis segment.
By Product & Service
Reagents & Consumables
-Assays & kits
-Enzymes
-DNA chips
-Others
Instruments
-PCR
-NGS
-DNA Microarrays
-Others
Service
-Gene Expression Analysis
-Bioinformatics Solutions
By Application
Drug Discovery & Development
Clinical Diagnostics
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa
10x Genomics Inc
Agilent Technologies Inc
BGI Genomics Co. Ltd
Bio-Rad Laboratories Inc
BioSpyder Inc
CD Genomics
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
GenScript Biotech Corp
Illumina Inc
Integrated DNA Technologies Inc
LGC Ltd
NanoString Technologies Inc
Oxford Gene Technology IP Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
Promega Corp
QIAGEN N.V.
Revvity Corp
Standard BioTools Inc
Takara Bio Inc
Thermo Fisher Scientific Inc
Twist Bioscience
Zymo Research Corp
*- List not Exhaustive
TABLE OF CONTENTS
1 Introduction to 2024 Gene Expression Analysis Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Gene Expression Analysis Market Size Outlook, $ Million, 2021 to 2030
3.2 Gene Expression Analysis Market Outlook by Type, $ Million, 2021 to 2030
3.3 Gene Expression Analysis Market Outlook by Product, $ Million, 2021 to 2030
3.4 Gene Expression Analysis Market Outlook by Application, $ Million, 2021 to 2030
3.5 Gene Expression Analysis Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Gene Expression Analysis Industry
4.2 Key Market Trends in Gene Expression Analysis Industry
4.3 Potential Opportunities in Gene Expression Analysis Industry
4.4 Key Challenges in Gene Expression Analysis Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Gene Expression Analysis Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Gene Expression Analysis Market Outlook by Segments
7.1 Gene Expression Analysis Market Outlook by Segments, $ Million, 2021- 2030
By Product & Service
Reagents & Consumables
-Assays & kits
-Enzymes
-DNA chips
-Others
Instruments
-PCR
-NGS
-DNA Microarrays
-Others
Service
-Gene Expression Analysis
-Bioinformatics Solutions
By Application
Drug Discovery & Development
Clinical Diagnostics
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
8 North America Gene Expression Analysis Market Analysis and Outlook To 2030
8.1 Introduction to North America Gene Expression Analysis Markets in 2024
8.2 North America Gene Expression Analysis Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Gene Expression Analysis Market size Outlook by Segments, 2021-2030
By Product & Service
Reagents & Consumables
-Assays & kits
-Enzymes
-DNA chips
-Others
Instruments
-PCR
-NGS
-DNA Microarrays
-Others
Service
-Gene Expression Analysis
-Bioinformatics Solutions
By Application
Drug Discovery & Development
Clinical Diagnostics
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
9 Europe Gene Expression Analysis Market Analysis and Outlook To 2030
9.1 Introduction to Europe Gene Expression Analysis Markets in 2024
9.2 Europe Gene Expression Analysis Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Gene Expression Analysis Market Size Outlook by Segments, 2021-2030
By Product & Service
Reagents & Consumables
-Assays & kits
-Enzymes
-DNA chips
-Others
Instruments
-PCR
-NGS
-DNA Microarrays
-Others
Service
-Gene Expression Analysis
-Bioinformatics Solutions
By Application
Drug Discovery & Development
Clinical Diagnostics
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
10 Asia Pacific Gene Expression Analysis Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Gene Expression Analysis Markets in 2024
10.2 Asia Pacific Gene Expression Analysis Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Gene Expression Analysis Market size Outlook by Segments, 2021-2030
By Product & Service
Reagents & Consumables
-Assays & kits
-Enzymes
-DNA chips
-Others
Instruments
-PCR
-NGS
-DNA Microarrays
-Others
Service
-Gene Expression Analysis
-Bioinformatics Solutions
By Application
Drug Discovery & Development
Clinical Diagnostics
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
11 South America Gene Expression Analysis Market Analysis and Outlook To 2030
11.1 Introduction to South America Gene Expression Analysis Markets in 2024
11.2 South America Gene Expression Analysis Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Gene Expression Analysis Market size Outlook by Segments, 2021-2030
By Product & Service
Reagents & Consumables
-Assays & kits
-Enzymes
-DNA chips
-Others
Instruments
-PCR
-NGS
-DNA Microarrays
-Others
Service
-Gene Expression Analysis
-Bioinformatics Solutions
By Application
Drug Discovery & Development
Clinical Diagnostics
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
12 Middle East and Africa Gene Expression Analysis Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Gene Expression Analysis Markets in 2024
12.2 Middle East and Africa Gene Expression Analysis Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Gene Expression Analysis Market size Outlook by Segments, 2021-2030
By Product & Service
Reagents & Consumables
-Assays & kits
-Enzymes
-DNA chips
-Others
Instruments
-PCR
-NGS
-DNA Microarrays
-Others
Service
-Gene Expression Analysis
-Bioinformatics Solutions
By Application
Drug Discovery & Development
Clinical Diagnostics
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
10x Genomics Inc
Agilent Technologies Inc
BGI Genomics Co. Ltd
Bio-Rad Laboratories Inc
BioSpyder Inc
CD Genomics
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
GenScript Biotech Corp
Illumina Inc
Integrated DNA Technologies Inc
LGC Ltd
NanoString Technologies Inc
Oxford Gene Technology IP Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
Promega Corp
QIAGEN N.V.
Revvity Corp
Standard BioTools Inc
Takara Bio Inc
Thermo Fisher Scientific Inc
Twist Bioscience
Zymo Research Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product & Service
Reagents & Consumables
-Assays & kits
-Enzymes
-DNA chips
-Others
Instruments
-PCR
-NGS
-DNA Microarrays
-Others
Service
-Gene Expression Analysis
-Bioinformatics Solutions
By Application
Drug Discovery & Development
Clinical Diagnostics
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
The global Gene Expression Analysis Market is one of the lucrative growth markets, poised to register a 7.4% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
10x Genomics Inc, Agilent Technologies Inc, BGI Genomics Co. Ltd, Bio-Rad Laboratories Inc, BioSpyder Inc, CD Genomics, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, GenScript Biotech Corp, Illumina Inc, Integrated DNA Technologies Inc, LGC Ltd, NanoString Technologies Inc, Oxford Gene Technology IP Ltd, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, Promega Corp, QIAGEN N.V., Revvity Corp, Standard BioTools Inc, Takara Bio Inc, Thermo Fisher Scientific Inc, Twist Bioscience, Zymo Research Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume